SOMAXON PHARMACEUTICALS, INC. Net Income
SOMAXON PHARMACEUTICALS, INC. reported Net Income of -$4.47 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-01.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2012-09-30 was -$4.47M.
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$2.20M.
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$2.12M.
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$10.26M.
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2011 was -$59.28M.
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2010 was -$38.81M.
- SOMAXON PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2009 was -$14.44M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$4.47M 10-Q · filed 2012-11-01 | -$6.67M derived: sum of 2 quarters · filed 2012-11-01 | -$8.79M 10-Q · filed 2012-11-01 | -$19.05M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-06-30 | -$2.20M 10-Q · filed 2012-08-08 | -$4.32M 10-Q · filed 2012-08-08 | -$14.58M derived: sum of 3 quarters · filed 2012-08-08 | -$31.61M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-03-31 | -$2.12M 10-Q · filed 2012-05-10 | -$12.38M derived: sum of 2 quarters · filed 2012-05-10 | -$29.41M derived: sum of 3 quarters · filed 2012-11-01 | -$44.36M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-12-31 | -$10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$27.29M derived: sum of 2 quarters · filed 2012-11-01 | -$42.24M derived: sum of 3 quarters · filed 2012-11-01 | -$59.28M 10-K · filed 2012-03-09 |
| 2011-09-30 | -$17.03M 10-Q · filed 2012-11-01 | -$31.98M derived: sum of 2 quarters · filed 2012-11-01 | -$49.02M 10-Q · filed 2012-11-01 | -$65.05M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | -$14.95M 10-Q · filed 2012-08-08 | -$31.99M 10-Q · filed 2012-08-08 | -$48.01M derived: sum of 3 quarters · filed 2012-08-08 | -$60.91M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | -$17.04M 10-Q · filed 2012-05-10 | -$33.06M derived: sum of 2 quarters · filed 2012-05-10 | -$45.97M derived: sum of 3 quarters · filed 2012-05-10 | -$51.69M derived: sum of 4 quarters · filed 2012-05-10 |
| 2010-12-31 | -$16.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$28.93M derived: sum of 2 quarters · filed 2012-03-09 | -$34.65M derived: sum of 3 quarters · filed 2012-03-09 | -$38.81M 10-K · filed 2012-03-09 |
| 2010-09-30 | -$12.90M 10-Q · filed 2011-11-04 | -$18.62M derived: sum of 2 quarters · filed 2011-11-04 | -$22.79M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | -$5.72M 10-Q · filed 2011-08-03 | -$9.89M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | -$14.44M 10-K · filed 2012-03-09 |